Eli Lilly’s Path to the Next Trillion Market Capitalization
LLY Eli Lilly and Company $951.00 -1.74 (-0.18%) (As of 10:46 AM ET) 52-Week Range $516.57 ▼ $972.53 Dividend Yield 0.55% P/E Ratio 140.06 Price Target $956.88 Eli Lilly and Co. NYSE: LLY is a pharmaceutical giant that’s made headlines for its GLP-1/GIP weight loss drug Tirzepatide, known as Mounjaro for type 2 diabetes, and Zepbound…